郭立中,毛炜,王红梅,刘玉宁,叶传蕙.肾康注射液对肾小球系膜细胞抑制作用的血清学研究[J].中国中西医结合杂志,2001,(7):531-533 |
肾康注射液对肾小球系膜细胞抑制作用的血清学研究 |
Serological Study on Inhibitory Function of Shenkang Injection on Glomerular Mesangial Cell |
免费下载全文 查看/发表评论 下载PDF阅读器 |
|
DOI: |
中文关键词: 肾康注射液 苯那普利 肾小球系膜细胞 肾小球硬化 |
英文关键词:Shenkang injection benazepril glomerular mesangial cell glomerulosclerosis |
基金项目:国家中医药管理局资助项目 (No .92D0 89) |
|
摘要点击次数: 1187 |
全文下载次数: 1596 |
中文摘要: |
目的 :探讨肾康注射液与苯那普利对人肾小球系膜细胞 (MC)增殖的不同抑制作用强度。方法 :采用体外培养的人肾小球系膜细胞技术和血清药理学方法 ,观察具有降逆泄浊、益气活血作用的中药肾康注射液及苯那普利对MC增殖的影响。结果 :肾康注射液与苯那普利对MC增殖均具有抑制作用 ,但在等效剂量浓度下 ,肾康注射液对MC的抑制作用优于苯那普利。结论 :MC是肾康注射液发挥治疗作用的重要靶细胞 ,抑制MC增殖可能是该方延缓肾小球硬化的重要机制之一。 |
英文摘要: |
To explore the intensity of inhibitory function of Shenkang injection (SKI), a Chinese herbal recipe, and benazepril on the proliferation of human glomerular mesangial cell (MC). Methods: The effect of SKI and benazepril on the proliferation of human MC was observed by using the cultured MC in vitro and serum pharmacological assay. Results: Both SKI and benazepril could inhibit the proliferation of human MC, but in equal dosage consistency, SKI showed a better inhibitory effect than that of benazepril. Conclusion: MC is the important target cell for the action of SKI, the inhibiting on proliferation might be one of the essential mechanisms of SKI in retarding glomerulosclerosis. |
关闭 |
|
|
|